AAAAAA
Results: 1-25/27
Authors:
Hoshikawa, Y
Ono, S
Suzuki, S
Tanita, T
Chida, M
Song, C
Noda, M
Tabata, T
Voelkel, NF
Fujimura, S
Citation: Y. Hoshikawa et al., Generation of oxidative stress contributes to the development of pulmonaryhypertension induced by hypoxia, J APP PHYSL, 90(4), 2001, pp. 1299-1306
Authors:
Geraci, MW
Gao, BF
Hoshikawa, Y
Yeager, ME
Tuder, RM
Voelkel, NF
Citation: Mw. Geraci et al., Genomic approaches to research in pulmonary hypertension, RESPIR RES, 2(4), 2001, pp. 210-215
Authors:
Hoshikawa, Y
Voelkel, NF
Gesell, TL
Moore, MD
Morris, KG
Alger, LA
Narumiya, S
Geraci, MW
Citation: Y. Hoshikawa et al., Prostacyclin receptor-dependent modulation of pulmonary vascular remodeling, AM J R CRIT, 164(2), 2001, pp. 314-318
Authors:
Kasahara, Y
Tuder, RM
Cool, CD
Lynch, DA
Flores, SC
Voelkel, NF
Citation: Y. Kasahara et al., Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema, AM J R CRIT, 163(3), 2001, pp. 737-744
Authors:
Tuder, RM
Yeager, ME
Geraci, M
Golpon, HA
Voelkel, NF
Citation: Rm. Tuder et al., Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene, EUR RESP J, 17(6), 2001, pp. 1065-1069
Authors:
Taraseviciene-Stewart, L
Kasahara, Y
Alger, L
Hirth, P
McMahon, G
Waltenberger, J
Voelkel, NF
Tuder, RM
Citation: L. Taraseviciene-stewart et al., Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension, FASEB J, 15(2), 2001, pp. 427-438
Authors:
Tuder, RM
Chacon, M
Alger, L
Wang, J
Taraseviciene-Stewart, L
Kasahara, Y
Cool, CD
Bishop, AE
Geraci, M
Semenza, GL
Yacoub, M
Polak, JM
Voelkel, NF
Citation: Rm. Tuder et al., Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis, J PATHOLOGY, 195(3), 2001, pp. 367-374
Authors:
Geraci, MW
Moore, M
Gesell, T
Yeager, ME
Alger, L
Golpon, H
Gao, BF
Loyd, JE
Tuder, RM
Voelkel, NF
Citation: Mw. Geraci et al., Gene expression patterns in the lungs of patients with primary pulmonary hypertension - A gene microarray analysis, CIRCUL RES, 88(6), 2001, pp. 555-562
Authors:
Yeager, ME
Halley, GR
Golpon, HA
Voelkel, NF
Tuder, RM
Citation: Me. Yeager et al., Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension, CIRCUL RES, 88(1), 2001, pp. E2-E11
Authors:
Tuder, RM
Voelkel, NF
Citation: Rm. Tuder et Nf. Voelkel, Plexiform lesion in severe pulmonary hypertension: Association with glomeruloid lesion, AM J PATH, 159(1), 2001, pp. 382-383
Authors:
Golpon, HA
Geraci, MW
Moore, MD
Miller, HL
Miller, GJ
Tuder, RM
Voelkel, NF
Citation: Ha. Golpon et al., HOX genes in human lung - Altered expression in primary pulmonary hypertension and emphysema, AM J PATH, 158(3), 2001, pp. 955-966
Authors:
Jakkula, M
Le Cras, TD
Gebb, S
Hirth, KP
Tuder, RM
Voelkel, NF
Abman, SH
Citation: M. Jakkula et al., Inhibition of angiogenesis decreases alveolarization in the developing ratlung, AM J P-LUNG, 279(3), 2000, pp. L600-L607
Authors:
Voelkel, NF
Citation: Nf. Voelkel, Hidden inflammatory potential of the red blood cell, CRIT CARE M, 28(6), 2000, pp. 2149-2150
Authors:
Voelkel, NF
Tuder, RM
Citation: Nf. Voelkel et Rm. Tuder, Hypoxia-induced pulmonary vascular remodeling: a model for what human disease?, J CLIN INV, 106(6), 2000, pp. 733-738
Authors:
Kasahara, Y
Tuder, RM
Taraseviciene-Stewart, L
Le Cras, TD
Abman, S
Hirth, PK
Waltenberger, J
Voelkel, NF
Citation: Y. Kasahara et al., Inhibition of VEGF receptors causes lung cell apoptosis and emphysema, J CLIN INV, 106(11), 2000, pp. 1311-1319
Authors:
Voelkel, NF
Citation: Nf. Voelkel, COPD: Working towards a greater understanding - Introduction, CHEST, 117(5), 2000, pp. 325S-325S
Authors:
Voelkel, NF
Citation: Nf. Voelkel, Raising awareness of COPD in primary care, CHEST, 117(5), 2000, pp. 372S-375S
Authors:
Voelkel, NF
Tuder, R
Citation: Nf. Voelkel et R. Tuder, COPD - Exacerbation, CHEST, 117(5), 2000, pp. 376S-379S
Authors:
Voelkel, MA
Wynne, KM
Badesch, DB
Groves, BM
Voelkel, NF
Citation: Ma. Voelkel et al., Hyperuricemia in severe pulmonary hypertension, CHEST, 117(1), 2000, pp. 19-24
Authors:
Voelkel, NF
Allard, JD
Anderson, SM
Burke, TJ
Citation: Nf. Voelkel et al., cGMP and cAMP cause pulmonary vasoconstriction in the presence of hemolysate, J APP PHYSL, 86(5), 1999, pp. 1715-1720
Authors:
Tuder, RM
Cool, CD
Geraci, MW
Wang, J
Abman, SH
Wright, L
Badesch, D
Voelkel, NF
Citation: Rm. Tuder et al., Prostacyclin synthase expression is decreased in lungs front patients withsevere pulmonary hypertension, AM J R CRIT, 159(6), 1999, pp. 1925-1932
Authors:
Quaife, RA
Lynch, D
Badesch, DB
Voelkel, NF
Lowes, BD
Robertson, AD
Bristow, MR
Citation: Ra. Quaife et al., Right ventricular phenotypic characteristics in subjects with primary pulmonary hypertension or idiopathic dilated cardiomyopathy, J CARD FAIL, 5(1), 1999, pp. 46-54
Authors:
Voelkel, NF
Tuder, RM
Citation: Nf. Voelkel et Rm. Tuder, Severe pulmonary hypertensive diseases: a perspective, EUR RESP J, 14(6), 1999, pp. 1246-1250
Authors:
Burke, TJ
Falk, S
Conger, JD
Voelkel, NF
Citation: Tj. Burke et al., Hemolysate-mediated renal vasoconstriction and hypersensitization, RENAL FAIL, 21(1), 1999, pp. 23-33
Authors:
Geraci, MW
Gao, BF
Shepherd, DC
Moore, MD
Westcott, JY
Fagan, KA
Alger, LA
Tuder, RM
Voelkel, NF
Citation: Mw. Geraci et al., Pulmonary prostacyclin, synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension, J CLIN INV, 103(11), 1999, pp. 1509-1515